Canine model of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia
- PMID: 16006551
- DOI: 10.1152/ajpheart.00083.2005
Canine model of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia
Abstract
Both autonomic nerve activity and electrical remodeling are important in atrial arrhythmogenesis. Therefore, dogs with sympathetic hyperinnervation, myocardial infarction (MI), and complete atrioventricular block (CAVB) may have a high incidence of atrial arrhythmias. We studied eight dogs (experimental group) with MI, CAVB, and sympathetic hyperinnervation induced either by nerve growth factor infusion (n = 4 dogs) or subthreshold electrical stimulation (n = 4 dogs) of the left stellate ganglion. Cardiac rhythm was continuously monitored by a Data Sciences International transmitter for 48 (SD 27) days. Three normal control dogs were also monitored. Six additional normal dogs were used for histology control. Paroxysmal atrial fibrillation (PAF) and paroxysmal atrial tachycardia (PAT) were documented in all dogs in the experimental group, with an average of 3.8 (SD 3) episodes/day, including 1.3 (SD 1.6) episodes of PAF and 2.5 (SD 2.2) episodes of PAT. The duration averaged 298 (SD 745) s (range, 7-4,000 s). There was a circadian pattern of arrhythmia onset (P < 0.01). Of 576 episodes of PAF and PAT, 236 (41%) episodes occurred during either sustained or nonsustained ventricular tachycardia (VT). Among these 236 episodes, 53% started before VT, whereas 47% started after the onset of VT. Normal dogs did not have either PAF or PAT. The hearts from the experimental group had a higher density of nerve structures immunopositive (P < 0.01) for three different nerve specific markers in both right and left atria than those of the control dogs. We conclude that the induction of nerve sprouting and sympathetic hyperinnervation in dogs with CAVB and MI creates a high yield model of PAF and PAT.
Similar articles
-
Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines.Circulation. 2008 Aug 26;118(9):916-25. doi: 10.1161/CIRCULATIONAHA.108.776203. Epub 2008 Aug 12. Circulation. 2008. PMID: 18697820 Free PMC article.
-
Antiarrhythmic effects of stimulating the left dorsal branch of the thoracic nerve in a canine model of paroxysmal atrial tachyarrhythmias.Heart Rhythm. 2018 Aug;15(8):1242-1251. doi: 10.1016/j.hrthm.2018.04.009. Epub 2018 Apr 11. Heart Rhythm. 2018. PMID: 29654853 Free PMC article.
-
What have we learned about the contribution of autonomic nervous system to human arrhythmia?Heart Rhythm. 2009 Aug;6(8 Suppl):S8-11. doi: 10.1016/j.hrthm.2009.02.015. Epub 2009 Feb 12. Heart Rhythm. 2009. PMID: 19631911
-
Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death.Cardiovasc Res. 2001 May;50(2):409-16. doi: 10.1016/s0008-6363(00)00308-4. Cardiovasc Res. 2001. PMID: 11334845 Review.
-
Autonomic nerve activity and atrial fibrillation.Heart Rhythm. 2007 Mar;4(3 Suppl):S61-4. doi: 10.1016/j.hrthm.2006.12.006. Epub 2006 Dec 15. Heart Rhythm. 2007. PMID: 17336887 Free PMC article. Review.
Cited by
-
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives.Antioxidants (Basel). 2024 Jul 2;13(7):806. doi: 10.3390/antiox13070806. Antioxidants (Basel). 2024. PMID: 39061875 Free PMC article. Review.
-
Methods for the development and assessment of atrial fibrillation and heart failure dog models.J Geriatr Cardiol. 2011 Sep;8(3):133-40. doi: 10.3724/SP.J.1263.2011.00133. J Geriatr Cardiol. 2011. PMID: 22783299 Free PMC article.
-
Ganglionated plexi and ligament of Marshall ablation reduces atrial vulnerability and causes stellate ganglion remodeling in ambulatory dogs.Heart Rhythm. 2016 Oct;13(10):2083-90. doi: 10.1016/j.hrthm.2016.07.014. Epub 2016 Jul 15. Heart Rhythm. 2016. PMID: 27426436 Free PMC article.
-
Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.Cardiovasc Drugs Ther. 2023 Jun;37(3):549-560. doi: 10.1007/s10557-022-07315-1. Epub 2022 Feb 9. Cardiovasc Drugs Ther. 2023. PMID: 35138505 Clinical Trial.
-
Atrial fibrillation: mechanisms, therapeutics, and future directions.Compr Physiol. 2015 Apr;5(2):649-65. doi: 10.1002/cphy.c140047. Compr Physiol. 2015. PMID: 25880508 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical